FDA Grant Establishes Complex Generics Center To Increase Access

Key Component Of The FDA’s Drug Competition Action Plan

 
• By Dean Rudge
  
FDAEntrance_1200x675
Complex products are a key component of the FDA’s Drug Competition Action Plan • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation